Cardiff Oncology (CRDF) Cash & Current Investments (2011 - 2026)
Cardiff Oncology (CRDF) posted Cash & Current Investments of $34.5 million for Q2 2026, down 51.4% from $71 million a year earlier.
Powered by 
Analysis
Cardiff Oncology (CRDF) Cash & Current Investments (2011 - 2026) Analysis & Trends
At the end of FY2025, Cardiff Oncology's Cash & Current Investments came in at $58.3 million, down 36.4% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -14.9% (FY2020 to FY2025).
- In prior years, Cardiff Oncology's Cash & Current Investments was $91.7 million in FY2024 (+22.6%), $74.82 million in FY2023 (-28.9%), $105.27 million in FY2022 (-25.2%) and $140.82 million in FY2021 (+7.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q2 2020.
- On a year-over-year basis, Cash & Current Investments increased in four of the last seven quarters, with an average decline of 7.5%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2021, with growth of 268.2%; the weakest was Q2 2026, with a decline of 51.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Cardiff Oncology | 62.34 Mn | 27.84 Mn | - | 34.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.50 Mn |
| Dec 31, 2025 | 58.30 Mn |
| Sep 30, 2025 | 60.60 Mn |
| Jun 30, 2025 | 71.00 Mn |
| Mar 31, 2025 | 79.90 Mn |
| Dec 31, 2024 | 91.70 Mn |
| Sep 30, 2024 | 57.70 Mn |
| Jun 30, 2024 | 60.32 Mn |
| Mar 31, 2024 | 67.19 Mn |
| Dec 31, 2023 | 74.82 Mn |
| Sep 30, 2023 | 81.36 Mn |
| Jun 30, 2023 | 89.43 Mn |
| Mar 31, 2023 | 96.97 Mn |
| Dec 31, 2022 | 105.27 Mn |
| Sep 30, 2022 | 114.30 Mn |
| Jun 30, 2022 | 122.01 Mn |
| Mar 31, 2022 | 129.36 Mn |
| Dec 31, 2021 | 140.82 Mn |
| Sep 30, 2021 | 134.05 Mn |
| Jun 30, 2021 | 140.05 Mn |
API Access
Cardiff Oncology Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();